Qualified Person Batch Release
The Qualified Person (QP) is the named individual, recognised under EU pharmaceutical law, who certifies that a batch has been manufactured and tested in accordance with Good Manufacturing Practice and the marketing authorisation before it is released for sale or supply. Certification is a personal, non-delegable act of professional judgement — it is the final gate between a manufactured batch and the patient, and it sits on top of, not inside, the quality unit’s routine disposition activity.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 20 LINKSCertification is a personal legal act, not a signature at the end of a workflow: the Qualified Person attests that this batch was made and checked in accordance with the authorisation, and carries that responsibility individually.
06 · QUALITY MATURITY — QUALIFIED PERSON BATCH RELEASE, REACTIVE TO ADAPTIVE
Certification is the last approval in the electronic workflow. What the certifier reviewed is not recorded and could not be reconstructed.
A defined dossier reaches the certifier, but it arrives complete only in the sense that every box is ticked; open deviations are summarised by the people who raised them.
The certifier decides what they need to see, has the standing to refuse, and the record shows which open items were judged and on what grounds.
Recurring causes of late or contested certification are fed back into manufacture, so the decision gets easier because the batches get better.
Certification is a confirmation of a process the certifier already has visibility of, and a refusal is a normal, survivable event rather than a crisis.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 3
Derived from the 3 standards SPEQ maps to this subject, across 3 regulatory bodies: FDA, ICH, PIC/S.
RECORDS & OBJECTIVE EVIDENCE
- The certification register, and the delegation or deputy arrangements covering absence
- The defined content of the release dossier the certifier receives
- Open deviation and investigation status at the point of certification, per batch
- Records of batches refused, held or certified with conditions, and the reasoning
- Evidence of the certifier’s own qualification and continuing knowledge of the products certified
COMMON INSPECTION FINDINGS
- Certification recorded with open investigations that the record does not show being considered
- A certifier with no practical route to refuse, or none recorded ever having been exercised
- Deputy arrangements undocumented, so absence is covered informally
- The release dossier defined by the software workflow rather than by the certifier
- Certification for product types the certifier has no demonstrated knowledge of
Role and Legal Basis
In the EU/EEA, no batch of medicinal product may be placed on the market unless a Qualified Person has certified that it was produced and checked in accordance with the laws in force and the marketing authorisation. The QP’s education, experience, and formal designation to a manufacturing authorisation are a regulatory prerequisite, not an internal job title — inspectors verify the QP’s standing directly against the site’s licence.
PIC/S member authorities apply an equivalent named-person release concept in their GMP guides, so the pattern — a designated individual whose certification is the release event — recurs across most GMP jurisdictions even where the title and legal mechanics differ from the EU model.
What Certification Actually Confirms
QP certification is not a paperwork sign-off appended to an already-complete process; it is an attestation that the batch record, deviations, in-process results, and finished-product testing collectively demonstrate GMP compliance and marketing-authorisation conformance for that specific batch. The QP must have access to the information needed to reach that judgement independently, including open deviations, OOS results, and any change not yet fully implemented.
Where part of manufacture was performed under a technical agreement at another site, the QP certifying the finished batch relies on the sending or intermediate site’s own GMP compliance status — which is why technology-transfer and contract-manufacturer oversight feed directly into the certification decision rather than sitting outside it.
The QP’s Relationship to the Quality Unit
The quality unit runs the operational disposition process — batch record review, specification checks, deviation closure, CAPA verification — that produces the evidence package. The QP’s certification is a distinct, accountable act layered on that evidence; a well-run quality system makes certification a confirmation of work already demonstrably complete, not the point where problems are first discovered.
SPEQ interpretation: sites sometimes conflate “QP release” with “quality unit approval” as if they were the same checkpoint performed by different people. Treating certification as a genuine independent review — with the authority to withhold it — is what keeps the control meaningful rather than ceremonial.
When Release Cannot Proceed
A QP cannot certify a batch with unresolved deviations, unexplained OOS results, incomplete validation status, or any open question bearing on whether the batch conforms to its authorisation — certification under those conditions is a falsifiable record, not a judgement call the QP is free to make either way. Batches held for further investigation stay in quarantine until the underlying question is closed, which is the mechanism that keeps a QMS honest under commercial pressure to ship.
FREQUENTLY ASKED
Is a Qualified Person the same as a US quality-unit release authority?
They perform an analogous function — a named accountable party certifying compliance before release — but the QP is a specific EU/EEA legal designation tied to a marketing authorisation and a manufacturing licence, with formal eligibility and notification requirements that do not map one-to-one onto FDA’s quality-unit release provisions under 21 CFR 211.
Can QP certification be delegated to a deputy?
A site may name more than one QP, and a designated deputy can certify batches within their own defined scope, but each certifying act remains a personal professional judgement made by whichever named QP performs it — it is not a task that can be waved through by an unnamed reviewer.
What happens if a QP refuses to certify a batch?
The batch stays unreleased. A refusal routes the batch back into investigation, CAPA, or rework as appropriate; there is no override path that lets commercial or supply pressure substitute for a resolved quality question.
Does QP certification cover the entire supply chain, including imported batches?
Imported batches from outside the EU/EEA require QP certification confirming equivalent GMP standards were applied, which is one reason mutual recognition agreements and PIC/S GMP alignment matter for manufacturers supplying into the EU from third countries.